UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019355
Receipt number R000022364
Scientific Title Efficacy of Autofluorescence imaging on flat adenoma detection; a randomized controlled trial
Date of disclosure of the study information 2015/10/20
Last modified on 2018/10/17 12:15:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Autofluorescence imaging on flat adenoma detection; a randomized controlled trial

Acronym

Efficacy of AFI on flat adenoma detection (A-FLAT trial)

Scientific Title

Efficacy of Autofluorescence imaging on flat adenoma detection; a randomized controlled trial

Scientific Title:Acronym

Efficacy of AFI on flat adenoma detection (A-FLAT trial)

Region

Japan


Condition

Condition

Colonic neoplasm

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of auto fluorescence imaging (AFI) for detection of flat colonic neoplasm compared to white light imaging (WLI)

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

detected number of flat colonic neoplasms per patient

Key secondary outcomes

detected number of colonic polyp per patient
Adenoma detection rate
Polyp detection rate
Advanced neoplasia detection rate
Detected number of advanced neoplasia per patient
Detected number of sessile serrated adenoma/polyp (SSA/P) per patient
Detected number of polyps according to morphology (flat/protruded)
Detected number of adenomas according to the size.
Procedure time (intubation and withdrawal time)
Adverse events


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

White light imaging

Interventions/Control_2

Autofluorescence imaging (AFI)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients undergoing colonoscopy for investigation of FIT, surveillance after polypectomy, or investigation for minor symptoms.
2. Patients obtained written informed consent.

Key exclusion criteria

1. Suspicious patient for advanced cancer.
2. Patient with IBD, polyposis, colon cancer, or colorectal polyps.
3. Patient with previous colorectomy or major abdominal surgery.
4. Patient with non-correctable coagulopathy.
5. Patient with severe organ failure.

Target sample size

800


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takahisa Matsuda

Organization

National Cancer Center Hospital

Division name

Research Center for Cancer Prevention and Screening

Zip code


Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan

TEL

03-3542-2511

Email

tamatsud@ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoji Takeuchi

Organization

Osaka International Cancer Institute

Division name

Gastrointestinal Oncology

Zip code


Address

3-1-69, Otemae, Chuo-ku, Osaka, Japan

TEL

06-6945-1181

Homepage URL


Email

takeuti-yo@mc.pref.osaka.jp


Sponsor or person

Institute

Endoscopic Forum Japan

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2015 Year 10 Month 02 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 20 Day

Last follow-up date

2017 Year 09 Month 12 Day

Date of closure to data entry

2017 Year 09 Month 13 Day

Date trial data considered complete

2017 Year 09 Month 13 Day

Date analysis concluded

2017 Year 10 Month 12 Day


Other

Other related information



Management information

Registered date

2015 Year 10 Month 15 Day

Last modified on

2018 Year 10 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022364


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2017/09/22 A-Flat:クリーニング後(UMIN登録用).xlsx